AtG is a spin-off company from the Bellvitge Biomedical Research Institute (IDIBELL) and the Catalan Institute of Oncology (ICO) in Barcelona that specialized in the discovery and development of new therapeutic techniques for cancer resistance to improve the lives of cancer patients.
Org chart
Collapse
No reports!
Teams
This company has no teams yet
